Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
PolyVascular
AddedFeb 19, 2024
UpdatedJun 18, 2026
PolyVascular

PolyVascular

Pre-Seed

PolyVascular: Innovating non-surgical, medical-grade polymer valves for transcatheter pulmonary use.

HQ
Houston, TX, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

PolyVascular was founded with the core mission of revolutionizing pediatric cardiac care by developing non-surgical, medical-grade polymer valves for transcatheter pulmonary use. Their vision is to improve the quality of life for children born with congenital heart defects by reducing the need for frequent open-heart surgeries. PolyVascular offers a unique, minimally invasive pulmonary valve and delivery system specifically designed for children as young as two years old, addressing a critical gap in pediatric cardiac treatment.

Notable affiliated individuals include experts in pediatric cardiology and medical device innovation. PolyVascular has attracted significant interest from investors focused on healthcare advancements. Key achievements include the development and successful implementation of their polymer valve technology, which has shown promise in reducing surgical interventions and improving patient outcomes. The overall impact of PolyVascular's innovations lies in their potential to transform pediatric cardiac care, offering safer and more effective treatment options for young patients worldwide.

PolyVascular - Similar Companies

Polynova Cardiovascular logo

Polynova Cardiovascular

Peca Labs logo

Peca Labs

pecalabs.com

Starlight Cardiovascular logo

Starlight Cardiovascular

Traverse Vascular logo

Traverse Vascular

Cross Vascular logo

Cross Vascular

VenoStent logo

VenoStent

venostent.com

Access Vascular logo

Access Vascular

Polares logo

Polares

polaresmedical.com

Bluegrass Vascular Technologies logo

Bluegrass Vascular Technologies

Attwill Vascular Technologies logo

Attwill Vascular Technologies

Vascular Perfusion Solutions logo

Vascular Perfusion Solutions

ValVention logo

ValVention

valvention.com

Pulsar Vascular logo

Pulsar Vascular

Amplitude Vascular Systems logo

Amplitude Vascular Systems

avspulse.com

TriFlo Cardiovascular logo

TriFlo Cardiovascular

triflocv.com

PolyVascular - Quick Facts

Who are PolyVascular's competitors?

Companies similar to PolyVascular include Polynova Cardiovascular, Peca Labs, Starlight Cardiovascular and Traverse Vascular.

When was PolyVascular founded?

PolyVascular was founded in 2014.

Where is PolyVascular's headquarters located?

PolyVascular's headquarters is located in Houston, TX, US.

When was PolyVascular's last funding round?

PolyVascular's most recent funding round was for $795k (USD) in July 2023.

How much has PolyVascular raised to-date?

As of Jul 17, 2023, PolyVascular has raised a total of $825k (USD).

How many employees does PolyVascular have?

PolyVascular has 13 employees as of Feb 5, 2024.

PolyVascular - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities